Condition
Malignant Mesothelioma
Estimated Enrollment: 36
Age Group: up to 75 Years (Child, Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Masking: Open Label|Primary Purpose: Treatment
Study ID Numbers: CDR0000486304|CASE-CCF-IRB-5179|CASE-CCF-0755
Study First Received: July 19, 2006
Last Updated: February 6, 2009
Estimated Primary Completion Date: null
Primary Outcome Measures:
Response to chemotherapy|Tolerability and toxicity|Relapse free and overall survival|Operability and surgical success|Quality of life
Sponsors and Collaborators:
Case Comprehensive Cancer Center|National Cancer Institute (NCI)
Website Link: https://ClinicalTrials.gov/show/NCT00354393
